Page last updated: 2024-11-06

prednisolone and Agnogenic Myeloid Metaplasia

prednisolone has been researched along with Agnogenic Myeloid Metaplasia in 43 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence."9.27Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response. ( Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y, 2018)
"A 73-year-old man with primary myelofibrosis (PMF) was being treated with hydroxyurea, which was changed to ruxolitinib treatment because of worsening constitutional symptoms."8.98Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature. ( Ikeda, M; Kiyasu, J; Ogawa, Y; Shiratsuchi, M; Tsuda, M; Tsukamoto, Y; Yufu, Y, 2018)
"Primary myelofibrosis was diagnosed in a 43-year-old female in 1991, who gradually became transfusion dependent."5.29[Primary myelofibrosis with positive coombs' test responding to prednisolone]. ( Okuda, T; Yoshida, Y; Yumoto, Y, 1996)
"Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence."5.27Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response. ( Fang, L; Hu, N; Huang, G; Li, B; Luo, X; Pan, L; Peter Gale, R; Qin, T; Qu, S; Xiao, Z; Xu, Z; Zhang, H; Zhang, P; Zhang, Y, 2018)
"A 73-year-old man with primary myelofibrosis (PMF) was being treated with hydroxyurea, which was changed to ruxolitinib treatment because of worsening constitutional symptoms."4.98Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature. ( Ikeda, M; Kiyasu, J; Ogawa, Y; Shiratsuchi, M; Tsuda, M; Tsukamoto, Y; Yufu, Y, 2018)
"Prednisolone was added if there was no response after 3 months in cohort 1 and based on up-front randomization in cohort 2 if there was no response at 3 or 6 months."2.84Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis. ( Benner, A; Blau, IW; Döhner, H; Döhner, K; Gattermann, N; Grießhammer, M; Hebart, H; Heidel, FH; Hochhaus, A; Jost, E; Kreipe, H; Platzbecker, U; Reiter, A; Schafhausen, P; Schlenk, RF; Stegelmann, F; Teleanu, V; Verbeek, W; Waller, C; Werner, M, 2017)
"We report two additional patients with acute myeloid leukemia (AML) and a translocation between chromosomes 7 and 11: t(7;11)(p15;p15)."2.38Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores. ( Fujimura, T; Iwabuchi, A; Kawakubo, K; Kodama, A; Ohyashiki, JH; Ohyashiki, K; Toyama, K, 1993)
"Oral prednisolone was initiated; it gradually improved his anemia and rendered the patient free of transfusion."1.37Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis. ( Hara, T; Hirose, Y; Kanemura, N; Kasahara, S; Moriwaki, H; Ninomiya, S; Ogawa, Y; Seishima, M; Tsurumi, H, 2011)
"Due to secondary myelofibrosis accompanied by Sjögren syndrome, she was started on prednisolone (PSL) and recovered completely from the anemia and thrombocytopenia."1.34[Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome]. ( Hattori, N; Maeda, T; Nakamaki, T; Nakashima, H; Tomoyasu, S; Usui, T; Yanagisawa, K, 2007)
"Myelofibrosis with myeloid metaplasia is defined as a myeloproliferative disorder characterized by leukoerythroblastosis, tear drop erythrocytes, extramedullary hematopoesis and varying degree of myelofibrosis."1.33Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia. ( Gulati, S; Jain, V; Kabra, M; Kalra, V; Maheshwari, A, 2005)
"Prednisolone was tapered off over the next 3 weeks."1.31Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil. ( Chao, TC; Chen, PM; Chiou, TJ; Hsiao, LT; Lin, JT; Liu, JH; Tai, CJ; Wang, WS; Yang, MH; Yen, CC, 2002)
"B-cell chronic lymphocytic leukemia (B-CLL) associated with bone marrow fibrosis is described."1.29Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis. ( Hyodo, H; Kimura, A; Kuramoto, A; Nakata, Y, 1993)
"This case was considered to be an acute myelofibrosis developed from myelodysplastic syndrome and worth to reporting with a review of literature, because drastic combination chemotherapy was extremely effective."1.29[Successful treatment with combination chemotherapy of BHAC-AMP in a case of acute myelofibrosis developed from myelodysplastic syndrome with multiple chromosomal aberrations]. ( Fujita, H; Hirayama, M; Kohgo, Y; Kura, T; Mogi, Y; Nakaya, R; Niitsu, Y; Tsuji, N; Watanabe, N, 1993)
"Primary myelofibrosis was diagnosed in a 43-year-old female in 1991, who gradually became transfusion dependent."1.29[Primary myelofibrosis with positive coombs' test responding to prednisolone]. ( Okuda, T; Yoshida, Y; Yumoto, Y, 1996)
"A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0."1.28[Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone]. ( Ikeda, Y; Kubo, A; Masuda, Y; Michikawa, N; Ogawa, T; Tanosaki, R; Uchida, H, 1992)
"The coexistence of myelofibrosis and pancytopenia in patients with systemic lupus erythematosus has been reported, but their possible causal relationship remains unresolved."1.27Myelofibrosis and pancytopenia in systemic lupus erythematosus. ( Ahmad, MA; al Fadel Saleh, M; al Gindan, YM; al Sohaibani, MO; el Mouzan, MI, 1988)
"A bone marrow biopsy disclosed severe myelofibrosis and many megakaryocytes, which appeared morphologically normal."1.27A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis. ( Hasselbalch, H; Jans, H; Nielsen, PL, 1987)
"All patients except one with aplastic anaemia responded with an increase in reticulocytes, haematocrit, red blood cell mass, and blood neutrophils and platelets."1.26Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure. ( Besa, EC; Dale, DC; Gardner, FH; Wolff, SM, 1977)
"Biopsy provided evidence for myelofibrosis with extramedullary erythropoiesis."1.26[Transitory myelofibrosis in a case of diaphyseal dysplasia (Camurati-Engelmann's disease) (author's transl)]. ( Bechrakis, G; Emons, D; Födisch, HJ; Hussel, D, 1978)
"Although splenomegaly was of only moderate degree, severe anemia and thrombocytopenia supervened."1.26Myelofibrosis and rapid thrombocytolysis. A case report. ( Bergström, AL; Kutti, J; Ridell, B, 1977)

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-199014 (32.56)18.7374
1990's9 (20.93)18.2507
2000's8 (18.60)29.6817
2010's12 (27.91)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohkawara, H1
Furukawa, M1
Ikeda, K1
Shichishima-Nakamura, A1
Fukatsu, M1
Sano, T1
Ueda, K1
Kimura, S1
Kanai, R1
Oka, Y1
Murakami, F1
Suzuki, O1
Hashimoto, Y1
Ogawa, K1
Ikezoe, T1
Tsukamoto, Y1
Kiyasu, J1
Tsuda, M1
Ikeda, M1
Shiratsuchi, M2
Ogawa, Y2
Yufu, Y1
Luo, X1
Xu, Z1
Li, B1
Qin, T1
Zhang, P1
Zhang, H1
Fang, L1
Pan, L1
Hu, N1
Qu, S1
Zhang, Y1
Huang, G1
Peter Gale, R1
Xiao, Z1
Hideki, M1
Tetsurou, T1
Sakae, F1
Kensei, K1
Makoto, O1
Toshinobu, K1
Shimoda, K1
Takenaka, K1
Kitanaka, A1
Akashi, K1
Takahashi, T1
Sekiguchi, Y1
Shirane, S1
Shimada, A1
Ichikawa, K1
Wakabayashi, M1
Sugimoto, K1
Tomita, S1
Izumi, H1
Nakamura, N1
Sawada, T1
Ohta, Y1
Komatsu, N1
Noguchi, M1
Schlenk, RF1
Stegelmann, F1
Reiter, A1
Jost, E1
Gattermann, N1
Hebart, H1
Waller, C1
Hochhaus, A1
Platzbecker, U1
Schafhausen, P1
Blau, IW1
Verbeek, W1
Heidel, FH1
Werner, M1
Kreipe, H1
Teleanu, V1
Benner, A1
Döhner, H1
Grießhammer, M1
Döhner, K1
Weinkove, R1
Reilly, JT1
McMullin, MF1
Curtin, NJ1
Radia, D1
Harrison, CN1
Mesa, RA1
Pardanani, AD1
Hussein, K1
Wu, W1
Schwager, S1
Litzow, MR1
Hogan, WJ1
Tefferi, A1
Sarkar, RN1
Banerjee, S1
Dey, S1
Saha, A1
Bhattacharjee, P1
Banerjee, TK1
Sinha, PK1
Chakraborty, A1
Takai, K1
Nikkuni, K1
Shibuya, H1
Hashidate, H1
Hattori, Y1
Miyakawa, Y1
Yokoyama, K1
Yamada, T1
Du, W1
Jinzaki, M1
Shinmoto, H1
Okamoto, S1
Ninomiya, S1
Hara, T1
Tsurumi, H1
Kanemura, N1
Kasahara, S1
Seishima, M1
Hirose, Y1
Moriwaki, H1
Lin, JT1
Wang, WS1
Yen, CC1
Chiou, TJ1
Liu, JH1
Hsiao, LT1
Yang, MH1
Chao, TC1
Tai, CJ1
Chen, PM1
PENGELLY, CD1
ROTHERMUNDT, A1
KIMBER, RJ1
LANDER, H1
ROBSON, HN1
Jain, V1
Maheshwari, A1
Gulati, S1
Kabra, M1
Kalra, V1
Hagihara, M1
Watanabe, S1
Suyama, T1
Sato, K1
Ito, A1
Umeda, M1
Koike, T1
Naruse, S1
Fujita, N1
Hattori, N1
Nakashima, H1
Usui, T1
Maeda, T1
Yanagisawa, K1
Nakamaki, T1
Tomoyasu, S1
Kueh, YK1
Oon, CJ1
Kimura, A1
Hyodo, H1
Nakata, Y1
Kuramoto, A1
Fujimura, T1
Ohyashiki, K1
Ohyashiki, JH1
Kawakubo, K1
Iwabuchi, A1
Kodama, A1
Toyama, K1
Tsuji, N1
Mogi, Y1
Nakaya, R1
Kura, T1
Fujita, H1
Hirayama, M1
Watanabe, N1
Kohgo, Y1
Niitsu, Y1
Imai, Y1
Akiyama, N1
Hanazono, Y1
Inamori, K1
Mitani, K1
Hirai, H1
Nagai, R1
Yazaki, Y1
Yumoto, Y1
Okuda, T1
Yoshida, Y1
Agarwal, BR1
Bhalla, K1
Dalvi, R1
Currimbhoy, ZE1
Mehta, KP1
Abe, Y1
Ohshima, K1
Honda, K1
Nishimura, J1
Nawata, H1
Muta, K1
Besa, EC1
Wolff, SM1
Dale, DC1
Gardner, FH1
Emons, D1
Hussel, D1
Bechrakis, G1
Födisch, HJ1
Kutti, J1
Bergström, AL1
Ridell, B1
Tanosaki, R1
Uchida, H1
Masuda, Y1
Michikawa, N1
Ogawa, T1
Kubo, A1
Ikeda, Y1
Narayanan, MN1
Benaim, ME1
Geary, CG1
Harrison, CJ1
Watts, EJ1
Majer, RV1
Green, PJ1
Mavor, WO1
el Mouzan, MI1
Ahmad, MA1
al Fadel Saleh, M1
al Sohaibani, MO1
al Gindan, YM1
Patterson, KG1
Treleaven, JG1
Zuiable, A1
Hasselbalch, H1
Jans, H1
Nielsen, PL1
Pyörälä, K1
Suhonen, O1
Pentikäinan, P1
Demidova, AV1
Barkhan, P1
Hauswaldt, C1
Hunseein, W1
Kaboth, U1
Lattermann, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multi-Center Phase II Study With Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage[NCT00949364]Phase 2103 participants (Actual)Interventional2009-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for prednisolone and Agnogenic Myeloid Metaplasia

ArticleYear
Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature.
    Internal medicine (Tokyo, Japan), 2018, May-01, Volume: 57, Issue:9

    Topics: Aged; Fatal Outcome; Humans; Hydroxyurea; Male; Prednisolone; Primary Myelofibrosis; Pyrazoles; Tube

2018
[Clinical aspects of primary myelofibrosis in Japan].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:3

    Topics: Blood Cell Count; Danazol; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Japan; Meth

2014
Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bone Marrow; Bone M

2015
Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.
    Cancer genetics and cytogenetics, 1993, Jul-15, Volume: 68, Issue:2

    Topics: Acute Disease; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Mar

1993

Trials

5 trials available for prednisolone and Agnogenic Myeloid Metaplasia

ArticleYear
Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.
    Blood cancer journal, 2018, 01-15, Volume: 8, Issue:1

    Topics: Adult; Aged; Anemia; Danazol; Female; Humans; Male; Middle Aged; Prednisolone; Primary Myelofibrosis

2018
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
    Leukemia, 2017, Volume: 31, Issue:4

    Topics: Aged; Aged, 80 and over; Alleles; Biomarkers; Chromosome Banding; Female; Humans; Immunologic Factor

2017
Low-dose thalidomide in myelofibrosis.
    Haematologica, 2008, Volume: 93, Issue:7

    Topics: Aged; Aged, 80 and over; Blood Transfusion; Female; Humans; Immunosuppressive Agents; Male; Middle A

2008
Phase1/-2 study of Pomalidomide in myelofibrosis.
    American journal of hematology, 2010, Volume: 85, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Inflammatory Agents; Female; Humans; Immunosuppressive

2010
Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.
    International journal of hematology, 2011, Volume: 93, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Fe

2011

Other Studies

34 other studies available for prednisolone and Agnogenic Myeloid Metaplasia

ArticleYear
Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-β in the bone marrow: a case report.
    International journal of hematology, 2017, Volume: 106, Issue:5

    Topics: Anemia, Hemolytic, Autoimmune; Bone Marrow; Drug Resistance; Female; Hepatitis, Autoimmune; Humans;

2017
Idiopathic myelofibrosis and pyoderma gangrenosum involving a mutation of Janus kinase 2 (JAK2V617F), showing poor prognosis.
    European journal of dermatology : EJD, 2013, Apr-01, Volume: 23, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Enterococcus; Fatal Outcome; Humans; Janus Kina

2013
Autoimmune myelofibrosis accompanied by Sjögren's syndrome in a 47, XXX/46, XX mosaic woman.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:7

    Topics: Adult; Chromosomes, Human, X; Female; Follow-Up Studies; Genetic Testing; Glucocorticoids; Humans; P

2014
Haematological presentation of systemic lupus erythematosus.
    The Journal of the Association of Physicians of India, 2009, Volume: 57

    Topics: Anemia, Hemolytic; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pancyt

2009
[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:5

    Topics: Ascites; Cyclosporine; Diagnosis, Differential; Fatal Outcome; Female; Fever; Hepatomegaly; Humans;

2010
Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:19

    Topics: Anemia; Bone Marrow; DNA Mutational Analysis; Humans; Janus Kinase 2; Male; Osteoarthropathy, Primar

2011
Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil.
    Annals of hematology, 2002, Volume: 81, Issue:12

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Refractory; Antineoplastic Combined Chemotherapy Proto

2002
STIMULATION OF RED-CELL PRODUCTION IN MYELOFIBROSIS WITH PREDNISOLONE.
    Postgraduate medical journal, 1964, Volume: 40

    Topics: Blood Transfusion; Erythropoiesis; Humans; Prednisolone; Primary Myelofibrosis

1964
[MASSIVE CELL INFILTRATION OF THE PULMONARY PARENCHYMA IN ALEUKEMIC CHRONIC MYELOSIS].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1964, Jul-01, Volume: 19

    Topics: Humans; Leukemia; Leukemia, Myeloid; Lung; Lung Diseases; Myeloproliferative Disorders; Pathology; P

1964
THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.
    The Journal of laboratory and clinical medicine, 1965, Volume: 65

    Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Ethylmaleimide; Hodgkin Disease; Humans; Liver; Liver Cirrh

1965
Juvenile rheumatoid arthritis with myelofibrosis with myeloid metaplasia.
    Indian journal of pediatrics, 2005, Volume: 72, Issue:9

    Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combinatio

2005
[Epstein-Barr virus related B-cell lymphoproliferative disorder complicated with bone marrow fibrosis, which was successfully treated with 2 courses of CHOP regimen].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; B-Lymphocytes; Cyclophosphamide; D

2005
[A case of dermatomyositis associated with chronic idiopathic myelofibrosis].
    Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Dermatomyositis; Drug Therapy, Combin

2006
[Successful treatment with prednisolone for autoimmune myelofibrosis accompanied with Sjögren syndrome].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:12

    Topics: Aged; Autoimmune Diseases; Female; Humans; Prednisolone; Primary Myelofibrosis; Sjogren's Syndrome

2007
Acute myelofibrosis (myelosclerosis) presenting as a case of severe thrombocytopenic purpura.
    Singapore medical journal, 1982, Volume: 23, Issue:1

    Topics: Acute Disease; Adult; Female; Humans; Prednisolone; Primary Myelofibrosis; Purpura, Thrombocytopenic

1982
Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
    American journal of hematology, 1993, Volume: 43, Issue:1

    Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Division; Cells, Cul

1993
[Successful treatment with combination chemotherapy of BHAC-AMP in a case of acute myelofibrosis developed from myelodysplastic syndrome with multiple chromosomal aberrations].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3

    Topics: Aclarubicin; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome

1993
[Successful treatment of splenomegaly and anemia by VP therapy in idiopathic myelofibrosis complicated with acromegaly: a case report].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:10

    Topics: Acromegaly; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Prednisolone

1995
[Primary myelofibrosis with positive coombs' test responding to prednisolone].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:3

    Topics: Adult; Coombs Test; Female; Glucocorticoids; Humans; Prednisolone; Primary Myelofibrosis

1996
Myelofibrosis secondary to SLE and its reversal on steroid therapy.
    Indian pediatrics, 1995, Volume: 32, Issue:11

    Topics: Biopsy, Needle; Bone Marrow; Child; Female; Follow-Up Studies; Glucocorticoids; Humans; Lupus Erythe

1995
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
    European journal of haematology, 2001, Volume: 66, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubi

2001
Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure.
    Lancet (London, England), 1977, Apr-02, Volume: 1, Issue:8014

    Topics: Adult; Aged; Anemia, Aplastic; Blood Cell Count; Cell Survival; Drug Combinations; Etiocholanolone;

1977
[Transitory myelofibrosis in a case of diaphyseal dysplasia (Camurati-Engelmann's disease) (author's transl)].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1978, Volume: 128, Issue:1

    Topics: Bone Diseases, Developmental; Camurati-Engelmann Syndrome; Child, Preschool; Humans; Male; Prednisol

1978
Myelofibrosis and rapid thrombocytolysis. A case report.
    Acta medica Scandinavica, 1977, Volume: 201, Issue:3

    Topics: Aged; Blood Cell Count; Blood Platelets; Bone Marrow; Cell Survival; Female; Hematopoiesis; Humans;

1977
[Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:2

    Topics: Bone Marrow; Female; Hematopoiesis; Humans; Middle Aged; Prednisolone; Primary Myelofibrosis

1992
Hyperfibrotic myelodysplasia.
    British journal of haematology, 1991, Volume: 79, Issue:4

    Topics: Blood Cell Count; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Primary Myel

1991
Hyperfibrotic myelodysplasia: a report of three cases showing haematological remission following treatment with prednisolone.
    British journal of haematology, 1991, Volume: 78, Issue:1

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Primary Mye

1991
Myelofibrosis and pancytopenia in systemic lupus erythematosus.
    Acta haematologica, 1988, Volume: 80, Issue:4

    Topics: Adolescent; Female; Humans; Lupus Erythematosus, Systemic; Pancytopenia; Prednisolone; Primary Myelo

1988
Marrow fibrosis in myeloma: improvement by alkylating agent therapy.
    Clinical and laboratory haematology, 1988, Volume: 10, Issue:2

    Topics: Alkylating Agents; Biopsy; Bone Marrow; Humans; Melphalan; Middle Aged; Multiple Myeloma; Prednisolo

1988
A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis.
    American journal of hematology, 1987, Volume: 25, Issue:2

    Topics: Adult; Autoimmune Diseases; Bone Marrow; Bone Marrow Cells; Diagnosis, Differential; Female; Humans;

1987
Steroid therapy and hyperosmolar non-ketotic coma.
    Lancet (London, England), 1968, Mar-16, Volume: 1, Issue:7542

    Topics: Adult; Diabetic Coma; Female; Glucocorticoids; Humans; Hydrocortisone; Lupus Erythematosus, Systemic

1968
[Primary myelofibrosis (osteomyelosclerosis). Current views on the pathogenesis, clinical course, diagnosis and therapy].
    Terapevticheskii arkhiv, 1974, Volume: 46, Issue:8

    Topics: Anabolic Agents; Antineoplastic Agents; Blood Transfusion; Humans; Methyltestosterone; Prednisolone;

1974
Blood and neoplastic diseases. Thrombocytopenia.
    British medical journal, 1974, May-11, Volume: 2, Issue:5914

    Topics: Aminocaproates; Anemia, Aplastic; Blood Transfusion; Bone Marrow Diseases; Female; Humans; Leukemia;

1974
[Animal experimental production of bone marrow fibroses using repeated injections of foreign protein and their medicamentous influencing through azathioprine and prednisolone].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1969, Volume: 75

    Topics: Animals; Azathioprine; Ovalbumin; Prednisolone; Primary Myelofibrosis; Rabbits

1969